Lynch, A. I., Boerwinkle, E., Davis, B. R., Ford, C. E., Eckfeldt, J. H., Leiendecker-Foster, C., & Arnett, D. K. (2009). Antihypertensive Pharmacogenetic Effect of Fibrinogen-beta Variant -455 G>A on Cardiovascular Disease, End-Stage Renal Disease and Mortality: The GenHAT Study.

Lynch, Amy I., Eric Boerwinkle, Barry R. Davis, Charles E. Ford, John H. Eckfeldt, Catherine Leiendecker-Foster, a Donna K. Arnett. Antihypertensive Pharmacogenetic Effect of Fibrinogen-beta Variant -455 G>A On Cardiovascular Disease, End-Stage Renal Disease and Mortality: The GenHAT Study. 2009.

Lynch, Amy I., et al. Antihypertensive Pharmacogenetic Effect of Fibrinogen-beta Variant -455 G>A On Cardiovascular Disease, End-Stage Renal Disease and Mortality: The GenHAT Study. 2009.